< Home < Back

Gland Pharma informs about press release

Date: 29-07-2026
Gland Pharma has informed that it enclosed press release titled ‘Gland Pharma receivesapproval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials.’

The above information is a part of company’s filings submitted to BSE.